Presenile cataract and its risk factors: A case control study.
Das GK, Boriwal K, Chhabra P, Sahu PK, Kumar S, Kumar N.
J Family Med Prim Care. 2019 Jun;8(6):2120-2123. doi: 10.4103/jfmpc.jfmpc_267_19.
Structural Characteristics of the Lens in Presenile Cataract.
Andjelic S, Drašlar K, Hvala A, Hawlina M.
Front Med (Lausanne). 2021 Dec 22;8:802275. doi: 10.3389/fmed.2021.802275. eCollection 2021.
Galactose and cataract.
Stambolian D.
Surv Ophthalmol. 1988 Mar-Apr;32(5):333-49. doi: 10.1016/0039-6257(88)90095-1.
Clinical Characteristics of Presenile Cataract: Change over 10 Years in Southern Taiwan.
Yu HJ, Kuo MT, Wu PC.
Biomed Res Int. 2021 Mar 20;2021:9385293. doi: 10.1155/2021/9385293. eCollection 2021.
Association of presenile cataract with galactose-1-phosphate uridyl transferase gene mutations.
Nema N, Kumar R, Verma A, Verma S, Chaturvedi K.
Natl Med J India. 2017 Mar-Apr;30(2):73-75.
Risk factors of presenile nuclear cataract in health screening study.
Nam SW, Lim DH, Cho KY, Kim HS, Kim K, Chung TY.
BMC Ophthalmol. 2018 Oct 11;18(1):263. doi: 10.1186/s12886-018-0928-6.
MYH9-Related Disease.
Savoia A, Pecci A.
2008 Nov 20 [updated 2021 Feb 18]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Scanning and transmission electron microscopy study of anterior lens epithelium in presenile cataract.
Wu J, Zhou J, Ping X, Xu X, Cui Y, Yang H, Yin Q, Shentu X.
Int Ophthalmol. 2020 Jun;40(6):1411-1418. doi: 10.1007/s10792-020-01307-6. Epub 2020 Mar 6.
[Presenile cataract].
PIETRUSCHKA G.
Ber Zusammenkunft Dtsch Ophthalmol Ges. 1961;64:183-8.
Presenile cataract: consider cholestanol.
Tészás A, Pfund Z, Morava E, Kosztolányi G, Sistermans E, Wevers RA, Kellermayer R.
Arch Ophthalmol. 2006 Oct;124(10):1490-2. doi: 10.1001/archopht.124.10.1490.
